Formulation and Evaluation of a Standardized Polyherbal Syrup with Optimized Pharmacological Activities

The current investigation is dedicated to the development and assessment of a standardised polyherbal syrup that has optimal pharmacological properties and incorporates the principles of pharmacognostic and current methods of analysis to guarantee effectiveness, safety and stability. The syrup was formulated based on aqueous extraction, hydro alcoholic extraction, physicochemical standardization and chromatographic fingerprinting (HPTLC, HPLC, FTIR). The syrup was composed of standardized extracts including Curcuma longa, Withania somnifera, Phyllanthus emblica, and Tinospora cordifolia. The preclinical animal research showed: large antioxidant, hepatoprotective, anti-inflammatory, and antidiabetic effects: the synergistic interaction between herbs and the optimization of pharmacodynamics. Toxicological analyses showed that it was safe with no adverse biochemical or histopathological changes at a dose of up to 2000 mg/kg. The formulation was highly stable with accelerated conditions and had a high level of phytochemical integrity. The implications of these findings are that, standardized polyherbal syrups can be a safe, effective, and reproducible therapeutic substitute to synthetic drugs, and future pharmacokinetic, mechanistic, and clinical studies are warranted.